Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Eisai launches new formulation of antiarrhythmic drug in Japan

Dec. 16, 1998

FDA grants expedited development status to Cordox as it begins phase III trials

Dec. 16, 1998

New prostanoid compound from Ono is a useful tool for studying cardiovascular system

Dec. 15, 1998

P&G submits NDA for antiarrhythmic drug azimilide

Dec. 14, 1998

Adenosine absorption inhibitors from Kyowa Hakko useful as antiinflammatories, cardioprotectants

Dec. 11, 1998

Carbostyril compounds useful for arteriosclerosis and thrombosis

Dec. 10, 1998

Competitive LPS antagonist E-5531 suppresses LPS-mediated effects in vitro and in vivo

Dec. 9, 1998

Pharmacyclics' photoangioplasty a hot topic at RSNA

Dec. 9, 1998

Electroporation catheter safely and effectively delivers heparin to arterial wall

Dec. 8, 1998

FDA approves Verelan PM; launch scheduled for early 1999

Dec. 4, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026